AHNTI EU 2026: 850+ trailblazers shape the future of animal health
Returning to the heart of London from 2-4 March, Animal Health, Nutrition & Technology Innovation Europe Summit (AHNTI EU) will connect 850+ industry trailblazers to discuss the future of animal health.
Technological advancements, evolving market dynamics, and new consumer demands have transformed the landscape, creating exciting opportunities for growth and change.
AHNTI EU 2026 offers a chance to reflect on the progress made and envision the next 10 years of animal health. Get ready for 3 days of in-depth discussions, interactive workshops and industry networking, providing a comprehensive overview of how innovation has and will continue to shape the animal health industry.
“This is THE EVENT to attend in animal health and is hands down the best investment made in terms of conferences in the past 12 months. As a newcomer to the industry, it is simply priceless.” – Davide Confalonieri, CEO, Lab4Paws
What you can expect…
- Hands-on learning: Join interactive workshops and roundtable sessions focused on using artificial intelligence to discover new technologies for livestock health and digital transformation.
- 1-2-1 networking: With 26 meeting slots available, our pre-scheduled meeting slots enable you to meet with industry peers and build new partnerships and collaborations.
- Innovation showcase: Discover the latest innovations across biopharma, nutrition, technology and diagnostics at the AHNTI EU Innovation Showcase.
New for 2026: From discovery to delivery
The Next Stage is where founders present their innovation story. Whether that’s reaching a regulatory milestone, closing a key funding round, or pivoting a business model, lessons learned will be shared with peers, investors, and industry partners.
This evolution is brought to life through the experiences of early and growth-stage companies navigating the realities of scaling. This year’s cohort brings together ventures tackling some of animal health’s most persistent unmet needs, each highlighting a different facet of what it takes to bring innovation to market.
Collectively, these stories reveal a shift in mindset: commercial readiness is emerging as the new measure of innovation. Scientific excellence remains essential, but it is only through regulatory foresight, strategic partnership, and effective investor communication that great ideas achieve meaningful impact.
Take a look at the companies hitting the stage this March here.
“The one must-attend event for any start-up. Every major and minor pharma is here and hungry. If you have something good, show up.” – Anthony Sasse, Managing Director, SnoreTox (Next Stage Speaker)
